HIV-derived vectors for gene therapy targeting dendritic cells

Advances in Experimental Medicine and Biology

Volumn 762, Issue , 2013, Pages 239-261

  Rossetti, Maura ^a   Cavarelli, Mariangela ^b   Gregori, Silvia ^a   Scarlatti, Gabriella ^b  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BLOOD CLOTTING FACTOR 9; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ANTIBODY; LENTIVIRUS VECTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TACROLIMUS; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; BIOSAFETY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INTERFERON PRODUCTION; INTERNAL RIBOSOME ENTRY SITE; INTERNALIZATION; LONG TERMINAL REPEAT; MONOCYTE; MYELOID DENDRITIC CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROVIRUS; T LYMPHOCYTE ACTIVATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS CELL INTERACTION; VIRUS REPLICATION;

DENDRITIC CELLS; GENETIC THERAPY; GENETIC VECTORS; HIV; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84869062794     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4433-6-9     Document Type: Article

References (138)

1. Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A et al (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296(5577): 2410-2413 (Pubitemid 34734219)
2. Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L et al (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360(5):447-458
3. Amendola M, Venneri MA, Biffi A, Vigna E, Naldini L (2005) Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol 23(1):108-116 (Pubitemid 41724633)
4. Amendola M, Passerini L, Pucci F, Gentner B, Bacchetta R, Naldini L (2009) Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform. Mol Ther 17(6):1039-1052
5. Andol fi G, Fousteri G, Rossetti M, Magnani C, Jofra T, Locafaro G, Bondanza A, Silvia Gregori S, Roncarolo MG (2012) Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4+ T Cells. Mol Ther. 2012 Jun 12 [ePub ahead of print].
6. Annoni A, Battaglia M, Follenzi A, Lombardo A, Sergi-Sergi L, Naldini L et al (2007) The immune response to lentiviral-delivered transgene is modulated in vivo by transgene-expressing antigen- presenting cells but not by CD4+ CD25+ regulatory T cells. Blood 110(6):1788-1796 (Pubitemid 47443889)
7. Annoni A, Brown BD, Cantore A, Sergi LS, Naldini L, Roncarolo MG (2009) In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance. Blood 114(25):5152-5161
8. Arce F, Rowe HM, Chain B, Lopes L, Collins MK (2009) Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization. Mol Ther 17(9):1643-1650
9. Arruda VR, Favaro P, Finn JD (2009) Strategies to modulate immune responses: a new frontier for gene therapy. Mol Ther 17(9):1492-1503
10. Bahner I, Sumiyoshi T, Kagoda M, Swartout R, Peterson D, Pepper K et al (2007) Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Mol Ther 15(1):76-85 (Pubitemid 46043652)
11. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K et al (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358(21):2231-2239 (Pubitemid 351724452)
12. Banasik MB, McCray PB Jr (2010) Integrase-defective lentiviral vectors: progress and applications. Gene Ther 17(2): 150-157
13. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S et al (2005) Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202(8):1131-1139 (Pubitemid 41464506)
14. Barron MA, Blyveis N, Palmer BE, MaWhinney S, Wilson CC (2003) Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis 187(1):26-37 (Pubitemid 36034468)
15. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG et al (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115(11):3265-3275 (Pubitemid 41567591)
16. Biffi A, Bartolomae CC, Cesana D, Cartier N, Aubourg P, Ranzani M et al (2011) Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 117(20):5332-5339
17. Breckpot K, Corthals J, Heirman C, Bonehill A, Michiels A, Tuyaerts S et al (2004) Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells. Hum Gene Ther 15(6):562-573 (Pubitemid 41071204)
18. Breckpot K, Emeagi PU, Thielemans K (2008) Lentiviral vectors for anti-tumor immunotherapy. Curr Gene Ther 8(6):438-448
19. Brown BD, Venneri MA, Zingale A, Sergi Sergi L, Naldini L (2006) Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 12(5):585-591
20. Brown BD, Cantore A, Annoni A, Sergi LS, Lombardo A, Della Valle P et al (2007a) A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110(13):4144-4152 (Pubitemid 351377775)
21. Brown BD, Sitia G, Annoni A, Hauben E, Sergi LS, Zingale A et al (2007b) In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109(7):2797-2805 (Pubitemid 46482074)
22. Browning MT, Schmidt RD, Lew KA, Rizvi TA (2001) Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J Virol 75(11):5129-5140 (Pubitemid 32448535)
23. Brussel A, Sonigo P (2004) Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species. J Virol 78(20):11263-11271 (Pubitemid 39299665)
24. Bukovsky AA, Song JP, Naldini L (1999) Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. J Virol 73(8):7087-7092 (Pubitemid 29327900)
25. Carbonneil C, Donkova-Petrini V, Aouba A, Weiss L (2004) Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+ CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha. J Immunol 172(12):7832-7840 (Pubitemid 38747651)
26. Chen X, He J, Chang LJ (2004) Alteration of T cell immunity by lentiviral transduction of human monocyte-derived dendritic cells. Retrovirology 1:37
27. Di Domizio J, Blum A, Gallagher-Gambarelli M, Molens JP, Chaperot L, Plumas J (2009) TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN. Blood 114(9):1794-1802
28. DiGiusto DL, Krishnan A, Li L, Li H, Li S, Rao A et al (2010) RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDSrelated lymphoma. Sci Transl Med 2(36):36ra43
29. Dillon SM, Robertson KB, Pan SC, Mawhinney S, Meditz AL, Folkvord JM et al (2008) Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J Acquir Immune Defic Syndr 48(1):1-12 (Pubitemid 351600852)
30. Donaghy H, Pozniak A, Gazzard B, Qazi N, Gilmour J, Gotch F et al (2001) Loss of blood CD11c(+) myeloid and CD11c(+) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98(8):2574-2576
31. Donaghy H, Gazzard B, Gotch F, Patterson S (2003) Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101(11): 4505-4511 (Pubitemid 36857821)
32. Dropulic B, Lin NH, Martin MA, Jeang KT (1992) Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression. J Virol 66(3): 1432-1441
33. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72(11):8463-8471 (Pubitemid 28471781)
34. Dullaers M, Van Meirvenne S, Heirman C, Straetman L, Bonehill A, Aerts JL et al (2006) Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors. Gene Ther 13(7):630-640
35. Duzgunes N, Simoes S, Konopka K, Rossi JJ, Pedroso de Lima MC (2001) Delivery of novel macromolecular drugs against HIV-1. Expert Opin Biol Ther 1(6):949-970
36. Dyall J, Latouche JB, Schnell S, Sadelain M (2001) Lentivirus-transduced human monocytederived dendritic cells Efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 97(1):114-121 (Pubitemid 32061250)
37. Ellis J (2005) Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 16(11):1241-1246 (Pubitemid 41611651)
38. Endres MJ, Jaffer S, Haggarty B, Turner JD, Doranz BJ, O'Brien PJ et al (1997) Targeting of HIVand SIV-infected cells by CD4-chemokine receptor pseudotypes. Science 278(5342):1462-1464 (Pubitemid 27509818)
39. Esslinger C, Chapatte L, Finke D, Miconnet I, Guillaume P, Levy F et al (2003) In vivo administration of a lentiviral vaccine targets DCs and induces Efficient CD8(+) T cell responses. J Clin Invest 111(11):1673-1681 (Pubitemid 38057749)
40. Follenzi A, Sabatino G, Lombardo A, Boccaccio C, Naldini L (2002) Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum Gene Ther 13(2):243-260 (Pubitemid 34164109)
41. Follenzi A, Battaglia M, Lombardo A, Annoni A, Roncarolo MG, Naldini L (2004) Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103(10): 3700-3709 (Pubitemid 38596285)
42. Follenzi A, Santambrogio L, Annoni A (2007) Immune responses to lentiviral vectors. Curr Gene Ther 7(5):306-315 (Pubitemid 47595773)
43. Fonteneau JF, Larsson M, Beignon AS, McKenna K, Dasilva I, Amara A et al (2004) Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 78(10):5223-5232 (Pubitemid 38581474)
44. Geijtenbeek TB, Van Kooyk Y (2003) Pathogens target DC-SIGN to Influence their fate DC-SIGN functions as a pathogen receptor with broad specificity. APMIS 111(7-8):698-714 (Pubitemid 37130018)
45. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8(8):594-606
46. Goudy KS, Annoni A, Naldini L, Roncarolo MG (2011) Manipulating immune tolerance with micro-RNA regulated gene therapy. Front Microbiol 2:221
47. Goujon C, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix JL, Cimarelli A (2003) Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells. J Virol 77(17):9295-9304 (Pubitemid 37011026)
48. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP, Steinman RM (2004) HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci U S A 101(20):7669-7674 (Pubitemid 38658087)
49. Granelli-Piperno A, Shimeliovich I, Pack M, Trumpfheller C, Steinman RM (2006) HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J Immunol 176(2):991-998 (Pubitemid 43099698)
50. Grassi F, Hosmalin A, McIlroy D, Calvez V, Debre P, Autran B (1999) Depletion in blood CD11cpositive dendritic cells from HIV-infected patients. AIDS 13(7):759-766 (Pubitemid 29224577)
51. Gruber A, Kan-Mitchell J, Kuhen KL, Mukai T, Wong-Staal F (2000) Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIVspecific cytotoxic T-lymphocyte response in vitro. Blood 96(4):1327-1333 (Pubitemid 30658460)
52. Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T et al (2006) Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med 203(8):1999-2008 (Pubitemid 44188473)
53. Harman AN, Wilkinson J, Bye CR, Bosnjak L, Stern JL, Nicholle M et al (2006) HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol 177(10):7103-7113 (Pubitemid 44715078)
54. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L et al (2008) Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adenoassociated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 19(10):979-990
55. Hodges A, Sharrocks K, Edelmann M, Baban D, Moris A, Schwartz O et al (2007) Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat Immunol 8(6):569-577 (Pubitemid 46785120)
56. Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K et al (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360(7):692-698
57. Joseph A, Zheng JH, Chen K, Dutta M, Chen C, Stiegler G et al (2010) Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody. J Virol 84(13):6645-6653
58. Kang Y, Xie L, Tran DT, Stein CS, Hickey M, Davidson BL et al (2005) Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer. Blood 106(5):1552-1558 (Pubitemid 41208565)
59. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA et al (2007) Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369(9579):2097-2105 (Pubitemid 46935946)
60. Kawamura T, Gatanaga H, Borris DL, Connors M, Mitsuya H, Blauvelt A (2003) Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells. J Immunol 170(8):4260-4266 (Pubitemid 36428193)
61. Keir ME, Stoddart CA, Linquist-Stepps V, Moreno ME, McCune JM (2002) IFN-alpha secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus. J Immunol 168(1):325-331 (Pubitemid 34014133)
62. Kim VN, Mitrophanous K, Kingsman SM, Kingsman AJ (1998) Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 72(1):811-816 (Pubitemid 28048905)
63. Krathwohl MD, Schacker TW, Anderson JL (2006) Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects. J Infect Dis 193(4):494-504 (Pubitemid 43202740)
64. Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M et al (2006) Immunogenicity and Efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus. Virology 351(1):133-144 (Pubitemid 44037663)
65. Leavitt MC, Yu M, Yamada O, Kraus G, Looney D, Poeschla E et al (1994) Transfer of an anti- HIV-1 ribozyme gene into primary human lymphocytes. Hum Gene Ther 5(9):1115-1120
66. Lee CL, Dang J, Joo KI, Wang P (2011) Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins. Virus Res 160(1-2):340-350
67. Lehmann C, Lafferty M, Garzino-Demo A, Jung N, Hartmann P, Fatkenheuer G et al (2010) Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients. PLoS One 5(6):e11110
68. Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, Wachihi C et al (2008) Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 22(6):685-694 (Pubitemid 351450636)
69. Limberis MP, Bell CL, Heath J, Wilson JM (2010) Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung. Mol Ther 18(1):143-150
70. Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275-306
71. Lizee G, Gonzales MI, Topalian SL (2004) Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells. Hum Gene Ther 15(4):393-404 (Pubitemid 38469781)
72. Lopes L, Fletcher K, Ikeda Y, Collins M (2006) Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy. Cancer Immunol Immunother 55(8):1011-1016 (Pubitemid 43673592)
73. Lore K, Sonnerborg A, Brostrom C, Goh LE, Perrin L, McDade H et al (2002) Accumulation of DC-SIGN+ CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 16(5):683-692 (Pubitemid 34274458)
74. Markusic DM, Van Til NP, Hiralall JK, Elferink RP, Seppen J (2009) Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domain. BMC Biotechnol 9:85
75. Marodon G (2001) CD4 down modulation on T-cells: an 'immune' checkpoint for HIV. Immunol Lett 79(3):165-168 (Pubitemid 32971888)
76. Marsac D, Loirat D, Petit C, Schwartz O, Michel ML (2002) Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gagspecific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles. J Virol 76(15):7544-7553 (Pubitemid 34760977)
77. Martinson JA, Roman-Gonzalez A, Tenorio AR, Montoya CJ, Gichinga CN, Rugeles MT et al (2007) Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands. Cell Immunol 250(1-2):75-84
78. Matrai J, Cantore A, Bartholomae CC, Annoni A, Wang W, Acosta-Sanchez A et al (2011) Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigenspecific tolerance in mice with low genotoxic risk. Hepatology 53(5):1696-1707
79. Mautino MR, Morgan RA (2000) Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA. Hum Gene Ther 11(14):2025-2037
80. Mebatsion T, Finke S, Weiland F, Conzelmann KK (1997) A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell 90(5):841-847 (Pubitemid 27381623)
81. Meera S, Madhuri T, Manisha G, Ramesh P (2010) Irreversible loss of pDCs by apoptosis during early HIV infection may be a critical determinant of immune dysfunction. Viral Immunol 23(3):241-249
82. Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S et al (2010) Dystrophin immunity in Duchenne's muscular dystrophy. N Engl J Med 363(15):1429-1437
83. Mingozzi F, Hasbrouck NC, Basner-Tschakarjan E, Edmonson SA, Hui DJ, Sabatino DE et al (2007) Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver. Blood 110(7):2334-2341 (Pubitemid 47523153)
84. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM (1998) Development of a self-inactivating lentivirus vector. J Virol 72(10):8150-8157
85. Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C et al (2006) Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24(6):687-696 (Pubitemid 43882120)
86. Montini E, Cesana D, Schmidt M, Sanvito F, Bartholomae CC, Ranzani M et al (2009) The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 119(4):964-975
87. Morelli AE, Thomson AW (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7(8):610-621 (Pubitemid 47123548)
88. Morris KV, Rossi JJ (2004) Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection. Curr HIV Res 2(2):185-191 (Pubitemid 38854930)
89. Morris KV, Gilbert J, Wong-Staal F, Gasmi M, Looney DJ (2004) Transduction of cell lines and primary cells by FIV-packaged HIV vectors. Mol Ther 10(1):181-190 (Pubitemid 38878160)
90. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272(5259):263-267 (Pubitemid 26119138)
91. Naldini L (1998) Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 9(5):457-463 (Pubitemid 28478965)
92. Nayak S, Herzog RW (2010) Progress and prospects: immune responses to viral vectors. Gene Ther 17(3):295-304
93. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK et al (2002) siRNAdirected inhibition of HIV-1 infection. Nat Med 8(7):681-686
94. Nowroozalizadeh S, Mansson F, da Silva Z, Repits J, Dabo B, Pereira C et al (2009) Studies on tolllike receptor stimuli responsiveness in HIV-1 and HIV-2 infections. Cytokine 46(3):325-331
95. Orchard PJ, Wagner JE (2011) Leukodystrophy and gene therapy with a dimmer switch. N Engl J Med 364(6):572-573
96. Pacanowski J, Kahi S, Baillet M, Lebon P, Deveau C, Goujard C et al (2001) Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98(10):3016-3021
97. Parker GA, Picut CA (2005) Liver immunobiology. Toxicol Pathol 33(1):52-62 (Pubitemid 40216804)
98. Patterson S, Donaghy H, Amjadi P, Gazzard B, Gotch F, Kelleher P (2005) Human BDCA-1- positive blood dendritic cells differentiate into phenotypically distinct immature and mature populations in the absence of exogenous maturational stimuli: differentiation failure in HIV infection. J Immunol 174(12):8200-8209 (Pubitemid 40806332)
99. Peretti S, Schiavoni I, Pugliese K, Federico M (2006) Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles. Virology 345(1):115-126 (Pubitemid 43107577)
100. Pichlmair A, Diebold SS, Gschmeissner S, Takeuchi Y, Ikeda Y, Collins MK et al (2007) Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9. J Virol 81(2):539-547 (Pubitemid 46067881)
101. Presicce P, Orsborn K, King E, Pratt J, Fichtenbaum CJ, Chougnet CA (2011) Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. PLoS One 6(12):e28118
102. Qin XF, An DS, Chen IS, Baltimore D (2003) Inhibiting HIV-1 infection in human T cells by lentiviral- mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 100(1):183-188 (Pubitemid 36078049)
103. Riley JL, Schlienger K, Blair PJ, Carreno B, Craighead N, Kim D et al (2000) Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule. J Exp Med 191(11):1987-1997 (Pubitemid 30390360)
104. Rossetti M, Gregori S, Hauben E, Brown BD, Sergi LS, Naldini L et al (2011) HIV-1-derived lentiviral vectors directly activate plasmacytoid dendritic cells, which in turn induce the maturation of myeloid dendritic cells. Hum Gene Ther 22(2):177-188
105. Rouas R, Uch R, Cleuter Y, Jordier F, Bagnis C, Mannoni P et al (2002) Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly Efficient transduction compatible with clinical constraints. Cancer Gene Ther 9(9): 715-724 (Pubitemid 34971302)
106. Rowe HM, Lopes L, Ikeda Y, Bailey R, Barde I, Zenke M et al (2006) Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. Mol Ther 13(2):310-319 (Pubitemid 43056896)
107. Sabado RL, O'Brien M, Subedi A, Qin L, Hu N, Taylor E et al (2010) Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 116(19):3839-3852
108. Salmon P, Arrighi JF, Piguet V, Chapuis B, Zubler RH, Trono D et al (2001) Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgeneexpressing immature and mature dendritic cells. J Gene Med 3(4):311-320 (Pubitemid 33691770)
109. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110(4):521-529 (Pubitemid 35232295)
110. Schroers R, Sinha I, Segall H, Schmidt-Wolf IG, Rooney CM, Brenner MK et al (2000) Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther 1(2):171-179
111. Sevilla N, McGavern DB, Teng C, Kunz S, Oldstone MB (2004) Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J Clin Invest 113(5):737-745 (Pubitemid 38544167)
112. Shimizu S, Hong P, Arumugam B, Pokomo L, Boyer J, Koizumi N et al (2010) A highly Efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood 115(8):1534-1544
113. Sinn PL, Burnight ER, Hickey MA, Blissard GW, McCray PB Jr (2005) Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol 79(20):12818-12827 (Pubitemid 41433201)
114. Sioud M, Drlica K (1991) Prevention of human immunodeficiency virus type 1 integrase expression in Escherichia coli by a ribozyme. Proc Natl Acad Sci U S A 88(16):7303-7307 (Pubitemid 21915139)
115. Sirven A, P fl umio F, Zennou V, Titeux M, Vainchenker W, Coulombel L et al (2000) The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96(13): 4103-4110
116. Smed-Sorensen A, Lore K, Walther-Jallow L, Andersson J, Spetz AL (2004) HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 104(9):2810-2817 (Pubitemid 39434966)
117. Smed-Sorensen A, Lore K, VasudeVan J, Louder MK, Andersson J, Mascola JR et al (2005) Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 79(14):8861-8869 (Pubitemid 40934796)
118. Soumelis V, Scott I, Gheyas F, Bouhour D, Cozon G, Cotte L et al (2001) Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98(4):906-912
119. Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99(1):351-358 (Pubitemid 34060366)
120. Stevenson M, Haggerty S, Lamonica CA, Meier CM, Welch SK, Wasiak AJ (1990) Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 64(5):2421-2425 (Pubitemid 20148495)
121. Sun LQ, Wang L, Gerlach WL, Symonds G (1995) Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res 23(15):2909-2913
122. Tan PH, Beutelspacher SC, Xue SA, Wang YH, Mitchell P, McAlister JC et al (2005) Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 105(10):3824-3832 (Pubitemid 40656124)
123. Tilton JC, Manion MM, Luskin MR, Johnson AJ, Patamawenu AA, Hallahan CW et al (2008) Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol 82(8):3997-4006 (Pubitemid 351521235)
124. Tsui LV, Kelly M, Zayek N, Rojas V, Ho K, Ge Y et al (2002) Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector. Nat Biotechnol 20(1):53-57 (Pubitemid 34044915)
125. Vanham G, Penne L, Devalck J, Kestens L, Colebunders R, Bosmans E et al (1999) Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol 117(2):335-342 (Pubitemid 29355090)
126. Veron P, Boutin S, Bernard J, Danos O, Davoust J, Masurier C (2006) Efficient transduction of monocyte- and CD34+-derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. J Gene Med 8(8):951-961 (Pubitemid 44282991)
127. Vigna E, Naldini L (2000) Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2(5):308-316
128. Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B (2005) HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 33(2):796-804 (Pubitemid 40361009)
129. White SM, Renda M, Nam NY, Klimatcheva E, Zhu Y, Fisk J et al (1999) Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol 73(4):2832-2840 (Pubitemid 29135670)
130. Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300(5626):1749-1751 (Pubitemid 36712571)
131. Yang L, Bailey L, Baltimore D, Wang P (2006) Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci U S A 103(31):11479-11484 (Pubitemid 44182477)
132. Ye Z, Harmison GG, Ragheb JA, Schubert M (2005) Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4. Retrovirology 2:80
133. Yonkers NL, Rodriguez B, Asaad R, Lederman MM, Anthony DD (2011) Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells. PLoS One 6(9):e23884
134. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P (2000) HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101(2):173-185 (Pubitemid 32004745)
135. Zhou C, Bahner IC, Larson GP, Zaia JA, Rossi JJ, Kohn EB (1994) Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149(1):33-39 (Pubitemid 24347697)
136. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves Efficient gene delivery in vivo. Nat Biotechnol 15(9):871-875
137. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L et al (1998) Self-inactivating lentivirus vector for safe and Efficient in vivo gene delivery. J Virol 72(12):9873-9880 (Pubitemid 28520853)
138. Zufferey R, Donello JE, Trono D, Hope TJ (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73(4):2886-2892 (Pubitemid 29135675)